BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24009274)

  • 21. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gelatinous degeneration of the bone marrow mimicking osseous metastasis on 18F-FDG PET/CT.
    Chong A; Song HC; Oh JR; Ha JM; Min JJ; Bom HS; Choi YD; Lee JS
    Clin Nucl Med; 2012 Aug; 37(8):798-800. PubMed ID: 22785516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. False-negative FDG-PET in histologically proven extensive large cell bone marrow involvement in diffuse large B-cell lymphoma.
    Adams HJ; de Klerk JM; Fijnheer R; Dubois SV; Nievelstein RA; Kwee TC
    Am J Hematol; 2015 Jul; 90(7):681. PubMed ID: 25703250
    [No Abstract]   [Full Text] [Related]  

  • 24. Non-Hodgkin lymphoma dominated by multiple organ extranodal disease revealed on FDG PET/CT.
    Bai X; Codreanu I; Kaplan SL; Servaes S; Zhuang H
    Clin Nucl Med; 2015 Apr; 40(4):360-3. PubMed ID: 25608171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match?
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Ann Nucl Med; 2015 Feb; 29(2):132-7. PubMed ID: 25348549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-FDG PET/CT diagnosis of vagus nerve neurolymphomatosis.
    Tsang HH; Lee EY; Anthony MP; Khong PL
    Clin Nucl Med; 2012 Sep; 37(9):897-8. PubMed ID: 22889783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of blind bone marrow biopsy on FDG-PET/CT interpretation of the posterior iliac crest in diffuse large B-cell lymphoma.
    Adams HJ; de Klerk JM; Fijnheer R; Dubois SV; Nievelstein RA; Kwee TC
    Hematol Oncol; 2016 Mar; 34(1):52-4. PubMed ID: 25308895
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging.
    Asenbaum U; Nolz R; Karanikas G; Furtner J; Woitek R; Staudenherz A; Senn D; Raderer M; Weber M; Simonitsch-Klupp I; Mayerhoefer ME
    PLoS One; 2016; 11(10):e0164118. PubMed ID: 27723817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FDG PET/CT Findings in Primary Diffuse Large B-cell Lymphoma, Leg Type.
    Ni C; Lewis M; Berenji G
    Clin Nucl Med; 2016 Jan; 41(1):65-8. PubMed ID: 26447379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of 18F-FDG PET/CT in identifying terminal ileal myeloid sarcoma in an asymptomatic patient.
    Lee EY; Leung AY; Anthony MP; Loong F; Khong PL
    Am J Hematol; 2011 Dec; 86(12):1036-7. PubMed ID: 21800353
    [No Abstract]   [Full Text] [Related]  

  • 31. [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.
    Martelli M; Ceriani L; Zucca E; Zinzani PL; Ferreri AJ; Vitolo U; Stelitano C; Brusamolino E; Cabras MG; Rigacci L; Balzarotti M; Salvi F; Montoto S; Lopez-Guillermo A; Finolezzi E; Pileri SA; Davies A; Cavalli F; Giovanella L; Johnson PW
    J Clin Oncol; 2014 Jun; 32(17):1769-75. PubMed ID: 24799481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic value of FDG-PET in the detection of bone marrow involvement in patients with diffuse large B-cell lymphoma].
    Zhang X; Fan W; Lin XP
    Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):832-5. PubMed ID: 19176040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of F-18 FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin's lymphoma.
    Agrawal K; Mittal BR; Bansal D; Varma N; Srinivasan R; Trehan A; Manohar K; Kashyap R; Bhattacharya A; Marwaha RK
    Ann Nucl Med; 2013 Feb; 27(2):146-51. PubMed ID: 23143537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18F-FDG PET/CT in the diagnosis of an extranodal relapse of diffuse large B-cell lymphoma (DLBCL): a clinical case with a literature review.
    Chaushev B; Micheva I; Mechmed M; Balev B; Bocheva Y; Ivanova D; Krasnaliev I; Lozanova R; Klisarova A; Bochev P; Dancheva J
    Nucl Med Rev Cent East Eur; 2016; 19(B):11-13. PubMed ID: 27813622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of bone marrow involvement in extranodal NK/T cell lymphoma by FDG-PET/CT.
    Zhou Z; Chen C; Li X; Li Z; Zhang X; Chang Y; Lu L; Cui Y; Ma Y; Zhang M
    Ann Hematol; 2015 Jun; 94(6):963-7. PubMed ID: 25547320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow involvement in diffuse large B-cell lymphoma: correlation between FDG-PET uptake and type of cellular infiltrate.
    Paone G; Itti E; Haioun C; Gaulard P; Dupuis J; Lin C; Meignan M
    Eur J Nucl Med Mol Imaging; 2009 May; 36(5):745-50. PubMed ID: 19096842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (18)FDG PET/CT appearance in primary cutaneous diffuse large B-cell lymphoma, leg type.
    Samarghandi A; Gru AA; Natwa M; Barker DW
    Clin Nucl Med; 2015 Jun; 40(6):506-8. PubMed ID: 25742229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Resistance to first line chemotherapy treatment in a patient diagnosed of nodular lymphocyte-predominant Hodgkin's lymphoma identified by 18F-FDG PET/CT: diagnostic and therapeutic implications].
    Banzo J; Ubieto MA; Giraldo P; Razola P; Prats E; Tardin L; Santapau A; Parra A; Rambalde EF; Velilla J
    Rev Esp Med Nucl Imagen Mol; 2012; 31(2):89-92. PubMed ID: 21620527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretherapy and posttherapy 18F-FDG PET/CT in isolated nasoseptal diffuse large B-cell lymphoma.
    Asa S; Aliyev A; Yılmaz S; Erkan ME; Sager S; Halac M
    Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):62-3. PubMed ID: 23177348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.